Myelodysplastic Syndromes Treatment (PDQ®): Patient Version | Aplastic Anemia & MDS International Foundation Return to top.

Myelodysplastic Syndromes Treatment (PDQ®): Patient Version

Journal Title: 
National Cancer Institute
Primary Author: 
PDQ Adult Treatment Editorial Board
PDQ Adult Treatment Editorial Board
Original Publication Date: 
Tuesday, March 19, 2019

This PDQ cancer information summary has current information about the treatment of myelodysplastic syndromes. It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care.

Editorial Boards write the PDQ cancer information summaries and keep them up to date. These Boards are made up of experts in cancer treatment and other specialties related to cancer. The summaries are reviewed regularly and changes are made when there is new information. The date on each summary ("Date Last Modified") is the date of the most recent change. The information in this patient summary was taken from the health professional version, which is reviewed regularly and updated as needed, by the PDQ Adult Treatment Editorial Board.

Bone Marrow Disease(s): 
  • myelodysplastic syndromes (MDS)
Share with